Paul Coplan, ScD

Johnson & Johnson

Poster(s):

• (C-136) Analysis of risk factors associated with 12-month incidence of pseudarthrosis following lumbar spinal fusion
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (SLC-013) Clinical Outcomes Among Patients Undergoing Lung Resection and Gastrointestinal Surgery Using Two Innovative Surgical Staplers in Routine Clinical Practice: A Multi-Institutional Database Study
  Tuesday, August 26, 2025

  12:15 PM - 1:15 PM ET

• (B-180) Comparative Risk of Hip and Knee Arthroplasty Among Medicare Beneficiaries Initiating GLP-1 Receptor Agonists vs. SGLT2 Inhibitors
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-179) Comparative Risk of Hip Fracture Among Medicare Beneficiaries Initiating GLP-1 Receptor Agonists vs. SGLT2 Inhibitors
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (C-135) Contemporary Trends in Catheter Ablation as First-Line Therapy Among Patients Diagnosed with Paroxysmal Atrial Fibrillation in Routine Clinical Practice in the United States
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (B-159) Do GLP-1 RA medications change the rate of total knee and hip replacement surgeries? Comparing different GLP-1 RA medications as a proxy of their effect
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (C-137) Does the risk of readmission and revision events after lumbar spine fusion differ in hospital billing versus claims data?
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (C-049) Epidemiology of intraoperative and postoperative complications in patients undergoing left-sided colorectal surgery for benign or malignant colorectal disease in England
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (B-169) Evaluation of completeness of patients’ follow up in a hospital healthcare database by matching with a closed claims database among atrial fibrillation patients
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET